Viewing Study NCT01510561


Ignite Creation Date: 2025-12-24 @ 12:36 PM
Ignite Modification Date: 2026-02-20 @ 4:44 PM
Study NCT ID: NCT01510561
Status: WITHDRAWN
Last Update Posted: 2021-08-19
First Post: 2012-01-05
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study of Fractionated 90Y-hPAM4 Plus Gemcitabine in Pancreatic Cancer Patients Receiving at Least 2 Prior Therapies.
Sponsor: Gilead Sciences
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Metastatic Pancreatic Adenocarcinoma View
None Pancreatic Cancer View
None Metastatic Pancreatic Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None metastatic pancreatic adenocarcinoma View
None pancreatic cancer View
None metastatic pancreatic cancer View